We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.09%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.62B
AUM Growth
+$874M
Cap. Flow
+$536M
Cap. Flow %
9.53%
Top 10 Hldgs %
66.07%
Holding
710
New
128
Increased
146
Reduced
103
Closed
149

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$779M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$358M
3
NEWR
New Relic, Inc.
NEWR
+$258M
4
DEN
Denbury Inc.
DEN
+$175M
5
VMW
VMware, Inc
VMW
+$165M

Top Sells

Rank Stock Value
1
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$230M
2
PDCE
PDC Energy, Inc.
PDCE
+$221M
3
UNVR
Univar Solutions Inc.
UNVR
+$219M
4
FOCS
Focus Financial Partners Inc. Class A
FOCS
+$146M
5
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$141M

Sector Composition

Rank Sector Weight
1 Technology 34.82%
2 Healthcare 28.77%
3 Real Estate 5.15%
4 Financials 4.39%
5 Consumer Discretionary 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AOGO
201
DELISTED
Arogo Capital Acquisition Corp. Class A Common Stock
AOGO
$2.42M 0.04%
226,579
– –
ALCE
202
DELISTED
Alternus Clean Energy Inc
ALCE
$2.35M 0.04%
8,902
– –
DXCM icon
203
DexCom
DXCM
$31.3B
$2.33M 0.04%
+25,000
New +$2.82M
PODD icon
204
Insulet
PODD
$9.66B
$2.3M 0.04%
+14,400
New +$3.22M
AXTA icon
205
Axalta
AXTA
$8.03B
$2.29M 0.04%
85,250
– –
GOOGL icon
206
Alphabet (Google) Class A
GOOGL
$4.38T
$2.29M 0.04%
17,500
-9,500
-35% -$1.23M
PTGX icon
207
Protagonist Therapeutics
PTGX
$9.46B
$2.27M 0.04%
136,268
+69,174
+103% +$1.34M
TMCI icon
208
Treace Medical Concepts
TMCI
$284M
$2.27M 0.04%
173,004
+60,551
+54% +$1.11M
FNVT
209
DELISTED
Finnovate Acquisition Corp. Class A Ordinary Shares
FNVT
$2.27M 0.04%
207,992
– –
COLD icon
210
Americold
COLD
$4.11B
$2.27M 0.04%
74,510
-14,591
-16% -$472K
AZEK
211
DELISTED
The AZEK Co
AZEK
$2.25M 0.04%
+75,800
New +$2.38M
META icon
212
Meta Platforms (Facebook)
META
$1.5T
$2.25M 0.04%
7,500
-21,000
-74% -$6.33M
ANAB icon
213
AnaptysBio
ANAB
$1.62B
$2.24M 0.04%
124,463
– –
BNL icon
214
Broadstone Net Lease
BNL
$4.06B
$2.23M 0.04%
+155,900
New +$2.5M
ZYME icon
215
Zymeworks
ZYME
$1.7B
$2.18M 0.04%
344,472
+25,000
+8% +$185K
MFA
216
MFA Financial
MFA
$915M
$2.18M 0.04%
226,894
-78,968
-26% -$854K
ARVN icon
217
Arvinas
ARVN
$568M
$2.16M 0.04%
110,182
+17,000
+18% +$417K
ATRC icon
218
AtriCure
ATRC
$2.01B
$2.16M 0.04%
49,293
+9,000
+22% +$439K
SWTX
219
DELISTED
SpringWorks Therapeutics
SWTX
$2.16M 0.04%
93,236
-22,397
-19% -$612K
SPEC
220
DELISTED
Spectaire Holdings, Inc. Common Stock
SPEC
$2.14M 0.04%
192,601
– –
ORIC icon
221
Oric Pharmaceuticals
ORIC
$1.34B
$2.13M 0.04%
351,502
-10,000
-3% -$81.9K
CXM icon
222
Sprinklr
CXM
$1.55B
$2.08M 0.04%
150,000
-118,318
-44% -$1.69M
IMCR icon
223
Immunocore
IMCR
$1.75B
$2.04M 0.04%
39,345
-1,000
-2% -$59.2K
IRTC icon
224
iRhythm Holdings
IRTC
$4.21B
$1.99M 0.04%
21,158
+8,629
+69% +$877K
HCMA
225
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$1.99M 0.04%
181,263
– –
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2023 Portfolio in Review

As of Q3 2023, UBS O'Connor held 710 positions worth $5.62B, up 18% from $4.75B the previous quarter. Its ten largest holdings account for 66% of the portfolio.

UBS O'Connor deployed $536M of net new capital in Q3 2023, opening 128 new positions and adding to 146 existing holdings. Its largest new stake was Denbury Inc.: 1,931,731 shares worth $189M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 16% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Seagen Inc. Common Stock, an estimated $19.7M trimmed.

  • UBS O'Connor's largest Q3 2023 buy was Denbury Inc.: 1,931,731 shares worth $189M.
  • UBS O'Connor added most to Activision Blizzard in Q3 2023, an estimated $779M increase.
  • UBS O'Connor's biggest Q3 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $19.7M.
  • UBS O'Connor fully exited IVERIC bio, Inc. Common Stock in Q3 2023, selling an estimated $230M.
  • UBS O'Connor's ten largest holdings make up 66% of its $5.62B portfolio in Q3 2023.
  • UBS O'Connor opened 128 new positions and closed 149 in Q3 2023.
  • UBS O'Connor's portfolio value rose 18% quarter-over-quarter to $5.62B.

Based on UBS O'Connor's 13F filing for Q3 2023, filed 14 Nov 2023.